CoNaIn agrees on primary schedules 6 months to 3 years once authorized by National Administration of Medicines, Food and Medica Technology ’(ANMAT); CoNaIn agrees to heterologous reinforcement schedules in children aged 3 and 4 years; Consensus meetings are recommended with the different scientific societies regarding vaccination of minors against COVID.
https://www.argentina.gob.ar/sites/default/files/2022/01/acta_conain_16_06_2022.pdf